Geldof AA - Search Results

1

In vitro protection from cisplatin-induced neurotoxicity by amifostine and its metabolite WR1065.

Verstappen CC, Geldof AA, Postma TJ, Heimans JJ. Verstappen CC, et al. Among authors: geldof aa. J Neurooncol. 1999 Aug;44(1):1-5. doi: 10.1023/a:1006241622639. J Neurooncol. 1999. PMID: 10582662

2

Amifostine protects against chemotherapy-induced neurotoxicity: an in vitro investigation.

Verstappen CC, Postma TJ, Geldof AA, Heimans JJ. Verstappen CC, et al. Among authors: geldof aa. Anticancer Res. 2004 Jul-Aug;24(4):2337-41. Anticancer Res. 2004. PMID: 15330181 Free article.

3

Vinca-alkaloid neurotoxicity measured using an in vitro model.

Geldof AA, Minneboo A, Heimans JJ. Geldof AA, et al. J Neurooncol. 1998 Apr;37(2):109-13. doi: 10.1023/a:1005848623771. J Neurooncol. 1998. PMID: 9524088

4

Nerve-growth-factor-dependent neurite outgrowth assay; a research model for chemotherapy-induced neuropathy.

Geldof AA. Geldof AA. J Cancer Res Clin Oncol. 1995;121(11):657-60. doi: 10.1007/BF01218523. J Cancer Res Clin Oncol. 1995. PMID: 7593129

5

Characterization of and protection from neurotoxicity induced by oxaliplatin, bortezomib and epothilone-B.

Ceresa C, Avan A, Giovannetti E, Geldof AA, Avan A, Cavaletti G, Peters GJ. Ceresa C, et al. Among authors: geldof aa. Anticancer Res. 2014 Jan;34(1):517-23. Anticancer Res. 2014. PMID: 24403510

6

Nerve growth factor stimulates in vitro invasive capacity of DU145 human prostatic cancer cells.

Geldof AA, De Kleijn MA, Rao BR, Newling DW. Geldof AA, et al. J Cancer Res Clin Oncol. 1997;123(2):107-12. doi: 10.1007/BF01269888. J Cancer Res Clin Oncol. 1997. PMID: 9030249

7

Synergism between cisplatin and radiotherapy in an in vitro prostate tumor cell line.

Geldof AA, Kruit A, Newling DW, Slotman BJ. Geldof AA, et al. Anticancer Res. 1999 Jan-Feb;19(1A):505-8. Anticancer Res. 1999. PMID: 10226589

8

Radiosensitizing effect of cisplatin in prostate cancer cell lines.

Geldof AA, Slotman BJ. Geldof AA, et al. Cancer Lett. 1996 Mar 29;101(2):233-9. doi: 10.1016/0304-3835(96)04140-7. Cancer Lett. 1996. PMID: 8620475

9

Cytotoxicity and neurocytotoxicity of new marine anticancer agents evaluated using in vitro assays.

Geldof AA, Mastbergen SC, Henrar RE, Faircloth GT. Geldof AA, et al. Cancer Chemother Pharmacol. 1999;44(4):312-8. doi: 10.1007/s002800050983. Cancer Chemother Pharmacol. 1999. PMID: 10447579

10

Consideration of the use of 17 beta-N,N-diethylcarbamoyl-4-methyl-4-aza-5- alpha-androstan-3-one (4MA), a 5 alpha-reductase inhibitor, in prostate cancer therapy.

Geldof AA, Meulenbroek MF, Dijkstra I, Bohlken S, Rao BR. Geldof AA, et al. J Cancer Res Clin Oncol. 1992;118(1):50-5. doi: 10.1007/BF01192311. J Cancer Res Clin Oncol. 1992. PMID: 1729259

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters